Logo image of ERO

ERO COPPER CORP (ERO) Stock Fundamental Analysis

USA - NYSE:ERO - CA2960061091 - Common Stock

22.69 USD
+0.61 (+2.76%)
Last: 10/20/2025, 8:04:01 PM
22.4634 USD
-0.23 (-1%)
After Hours: 10/20/2025, 8:04:01 PM
Fundamental Rating

5

We assign a fundamental rating of 5 out of 10 to ERO. ERO was compared to 155 industry peers in the Metals & Mining industry. While ERO has a great profitability rating, there are quite some concerns on its financial health. ERO is growing strongly while it also seems undervalued. This is an interesting combination


Dividend Valuation Growth Profitability Health

8

1. Profitability

1.1 Basic Checks

In the past year ERO was profitable.
ERO had a positive operating cash flow in the past year.
Of the past 5 years ERO 4 years were profitable.
In the past 5 years ERO always reported a positive cash flow from operatings.
ERO Yearly Net Income VS EBIT VS OCF VS FCFERO Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M

1.2 Ratios

ERO's Return On Assets of 8.05% is amongst the best of the industry. ERO outperforms 85.81% of its industry peers.
ERO has a better Return On Equity (17.33%) than 90.97% of its industry peers.
Looking at the Return On Invested Capital, with a value of 9.33%, ERO belongs to the top of the industry, outperforming 80.65% of the companies in the same industry.
Measured over the past 3 years, the Average Return On Invested Capital for ERO is below the industry average of 12.30%.
The last Return On Invested Capital (9.33%) for ERO is above the 3 year average (8.14%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 8.05%
ROE 17.33%
ROIC 9.33%
ROA(3y)3.34%
ROA(5y)9.91%
ROE(3y)6.26%
ROE(5y)18.84%
ROIC(3y)8.14%
ROIC(5y)19.2%
ERO Yearly ROA, ROE, ROICERO Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40

1.3 Margins

The Profit Margin of ERO (26.62%) is better than 90.97% of its industry peers.
ERO has a better Operating Margin (32.35%) than 84.52% of its industry peers.
In the last couple of years the Operating Margin of ERO has remained more or less at the same level.
ERO has a Gross Margin of 42.71%. This is amongst the best in the industry. ERO outperforms 80.65% of its industry peers.
ERO's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 32.35%
PM (TTM) 26.62%
GM 42.71%
OM growth 3Y-22.63%
OM growth 5Y-1.37%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-16.13%
GM growth 5Y-1.36%
ERO Yearly Profit, Operating, Gross MarginsERO Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40 60

1

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so ERO is still creating some value.
Compared to 1 year ago, ERO has more shares outstanding
ERO has more shares outstanding than it did 5 years ago.
The debt/assets ratio for ERO is higher compared to a year ago.
ERO Yearly Shares OutstandingERO Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
ERO Yearly Total Debt VS Total AssetsERO Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

2.2 Solvency

ERO has an Altman-Z score of 2.55. This is not the best score and indicates that ERO is in the grey zone with still only limited risk for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 2.55, ERO is in line with its industry, outperforming 41.94% of the companies in the same industry.
A Debt/Equity ratio of 0.70 indicates that ERO is somewhat dependend on debt financing.
ERO's Debt to Equity ratio of 0.70 is on the low side compared to the rest of the industry. ERO is outperformed by 82.58% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.7
Debt/FCF N/A
Altman-Z 2.55
ROIC/WACC1.11
WACC8.37%
ERO Yearly LT Debt VS Equity VS FCFERO Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M 400M 600M 800M

2.3 Liquidity

A Current Ratio of 0.84 indicates that ERO may have some problems paying its short term obligations.
With a Current ratio value of 0.84, ERO is not doing good in the industry: 89.03% of the companies in the same industry are doing better.
A Quick Ratio of 0.52 indicates that ERO may have some problems paying its short term obligations.
ERO has a Quick ratio of 0.52. This is amonst the worse of the industry: ERO underperforms 89.68% of its industry peers.
Industry RankSector Rank
Current Ratio 0.84
Quick Ratio 0.52
ERO Yearly Current Assets VS Current LiabilitesERO Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M

7

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 71.23% over the past year.
ERO shows a decrease in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -2.60% yearly.
ERO shows a strong growth in Revenue. In the last year, the Revenue has grown by 20.59%.
ERO shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 10.55% yearly.
EPS 1Y (TTM)71.23%
EPS 3Y-30.56%
EPS 5Y-2.6%
EPS Q2Q%155.56%
Revenue 1Y (TTM)20.59%
Revenue growth 3Y-1.36%
Revenue growth 5Y10.55%
Sales Q2Q%39.63%

3.2 Future

Based on estimates for the next years, ERO will show a very strong growth in Earnings Per Share. The EPS will grow by 21.30% on average per year.
The Revenue is expected to grow by 11.24% on average over the next years. This is quite good.
EPS Next Y163.4%
EPS Next 2Y88.5%
EPS Next 3Y56.19%
EPS Next 5Y21.3%
Revenue Next Year57.74%
Revenue Next 2Y43.85%
Revenue Next 3Y27.97%
Revenue Next 5Y11.24%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
ERO Yearly Revenue VS EstimatesERO Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 200M 400M 600M 800M 1B
ERO Yearly EPS VS EstimatesERO Yearly EPS VS EstimatesYearly EPS VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 1 2

7

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 18.15, which indicates a rather expensive current valuation of ERO.
ERO's Price/Earnings ratio is rather cheap when compared to the industry. ERO is cheaper than 86.45% of the companies in the same industry.
ERO's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 27.69.
ERO is valuated reasonably with a Price/Forward Earnings ratio of 8.19.
Based on the Price/Forward Earnings ratio, ERO is valued cheaper than 94.19% of the companies in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 23.18, ERO is valued rather cheaply.
Industry RankSector Rank
PE 18.15
Fwd PE 8.19
ERO Price Earnings VS Forward Price EarningsERO Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, ERO is valued a bit cheaper than 73.55% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 11.09
ERO Per share dataERO EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6

4.3 Compensation for Growth

ERO's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
The excellent profitability rating of ERO may justify a higher PE ratio.
A more expensive valuation may be justified as ERO's earnings are expected to grow with 56.19% in the coming years.
PEG (NY)0.11
PEG (5Y)N/A
EPS Next 2Y88.5%
EPS Next 3Y56.19%

0

5. Dividend

5.1 Amount

No dividends for ERO!.
Industry RankSector Rank
Dividend Yield N/A

ERO COPPER CORP

NYSE:ERO (10/20/2025, 8:04:01 PM)

After market: 22.4634 -0.23 (-1%)

22.69

+0.61 (+2.76%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryMetals & Mining
Earnings (Last)07-31 2025-07-31/amc
Earnings (Next)11-04 2025-11-04/amc
Inst Owners74.32%
Inst Owner Change0.15%
Ins Owners6.14%
Ins Owner ChangeN/A
Market Cap2.35B
Analysts81.11
Price Target19.13 (-15.69%)
Short Float %4.37%
Short Ratio5.54
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)43.75%
Min EPS beat(2)11.2%
Max EPS beat(2)76.3%
EPS beat(4)2
Avg EPS beat(4)6.18%
Min EPS beat(4)-44.95%
Max EPS beat(4)76.3%
EPS beat(8)4
Avg EPS beat(8)7.42%
EPS beat(12)5
Avg EPS beat(12)-2.7%
EPS beat(16)6
Avg EPS beat(16)-5.04%
Revenue beat(2)0
Avg Revenue beat(2)-5.09%
Min Revenue beat(2)-6.41%
Max Revenue beat(2)-3.77%
Revenue beat(4)0
Avg Revenue beat(4)-11.95%
Min Revenue beat(4)-20.39%
Max Revenue beat(4)-3.77%
Revenue beat(8)1
Avg Revenue beat(8)-7.79%
Revenue beat(12)3
Avg Revenue beat(12)-6.75%
Revenue beat(16)5
Avg Revenue beat(16)-5.93%
PT rev (1m)0.05%
PT rev (3m)-4.15%
EPS NQ rev (1m)0.47%
EPS NQ rev (3m)-8.44%
EPS NY rev (1m)0.09%
EPS NY rev (3m)-4.52%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-5.05%
Revenue NY rev (1m)0.16%
Revenue NY rev (3m)-5.31%
Valuation
Industry RankSector Rank
PE 18.15
Fwd PE 8.19
P/S 4.39
P/FCF N/A
P/OCF 8.73
P/B 2.86
P/tB 2.86
EV/EBITDA 11.09
EPS(TTM)1.25
EY5.51%
EPS(NY)2.77
Fwd EY12.21%
FCF(TTM)-0.16
FCFYN/A
OCF(TTM)2.6
OCFY11.45%
SpS5.17
BVpS7.95
TBVpS7.95
PEG (NY)0.11
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 8.05%
ROE 17.33%
ROCE 11.11%
ROIC 9.33%
ROICexc 9.75%
ROICexgc 9.75%
OM 32.35%
PM (TTM) 26.62%
GM 42.71%
FCFM N/A
ROA(3y)3.34%
ROA(5y)9.91%
ROE(3y)6.26%
ROE(5y)18.84%
ROIC(3y)8.14%
ROIC(5y)19.2%
ROICexc(3y)9.9%
ROICexc(5y)23.79%
ROICexgc(3y)9.9%
ROICexgc(5y)23.79%
ROCE(3y)9.69%
ROCE(5y)22.87%
ROICexcg growth 3Y-45.44%
ROICexcg growth 5Y-14.21%
ROICexc growth 3Y-45.44%
ROICexc growth 5Y-14.21%
OM growth 3Y-22.63%
OM growth 5Y-1.37%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-16.13%
GM growth 5Y-1.36%
F-Score7
Asset Turnover0.3
Health
Industry RankSector Rank
Debt/Equity 0.7
Debt/FCF N/A
Debt/EBITDA 2.23
Cap/Depr 333.17%
Cap/Sales 53.24%
Interest Coverage 4.47
Cash Conversion 103.91%
Profit Quality N/A
Current Ratio 0.84
Quick Ratio 0.52
Altman-Z 2.55
F-Score7
WACC8.37%
ROIC/WACC1.11
Cap/Depr(3y)480.9%
Cap/Depr(5y)425.39%
Cap/Sales(3y)82.97%
Cap/Sales(5y)64.48%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)71.23%
EPS 3Y-30.56%
EPS 5Y-2.6%
EPS Q2Q%155.56%
EPS Next Y163.4%
EPS Next 2Y88.5%
EPS Next 3Y56.19%
EPS Next 5Y21.3%
Revenue 1Y (TTM)20.59%
Revenue growth 3Y-1.36%
Revenue growth 5Y10.55%
Sales Q2Q%39.63%
Revenue Next Year57.74%
Revenue Next 2Y43.85%
Revenue Next 3Y27.97%
Revenue Next 5Y11.24%
EBIT growth 1Y92.66%
EBIT growth 3Y-23.68%
EBIT growth 5Y9.03%
EBIT Next Year194.25%
EBIT Next 3Y61.44%
EBIT Next 5Y24.76%
FCF growth 1Y93.43%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y80.87%
OCF growth 3Y-26.39%
OCF growth 5Y2.62%